We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.

While these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilising our proprietary ProTide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.



Contact Us

Global Headquarters

3 Lochside Way
EH12 9DT. United Kingdom

Telephone: +44 (0)131 357 1111
E-mail: info@nucana.com

U.S. Offices

275 Grove Street
MA 02466

Telephone: +1 617 663 4821
E-mail: info@nucana.com